Sensei Biotherapeutics, Inc. · NASDAQ:SNSE
Caligan Partners LP's stake in Sensei Biotherapeutics, Inc. fell to 2.40% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Caligan Partners LP's stake in Sensei Biotherapeutics, Inc. fell to 2.40%, 629,467 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 2.40%
- Shares
- 629,467
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Caligan Partners LP | 2.40% | 629,467 |
| David Johnson | 2.40% | 629,467 |
Source
Related
- Sensei Biotherapeutics, Inc.
- Caligan Partners LP
- Sensei Biotherapeutics, Inc. shareholders
- Schedule 13G · Caligan Partners LP · May 15, 2026
- Schedule 13G/A · Stempoint Capital LP · Aug 14, 2026
- Schedule 13G · VK Services, LLC · Aug 14, 2026
- Schedule 13G/A · Trails Edge Capital Partners, LP · Aug 14, 2026
- Schedule 13G · Montanova Capital, LLC · Jun 23, 2026
- Schedule 13G · S2G Investments, LLC · Jun 23, 2026